查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
疼痛管理藥的全球市場 (2022年～2031年):產業分析·規模·佔有率·成長·趨勢·預測
市場調查報告書
商品編碼
1166051

疼痛管理藥的全球市場 (2022年～2031年):產業分析·規模·佔有率·成長·趨勢·預測

Pain Management Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
出版日期: | 出版商: Transparency Market Research | 英文 166 Pages | 商品交期: 2-10個工作天內

價格

本報告提供全球疼痛管理藥的市場調查，彙整市場概要，市場成長的各種影響因素分析，開發平台分析，市場規模的轉變·預測，各種區分·各地區/主要國家的明細，競爭環境，主要企業簡介等資訊。

目錄

第1章 序文

第2章 前提·調查手法

第3章 摘要整理:全球疼痛管理藥市場

第4章 市場概要

  • 概要
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 機會
  • 全球疼痛管理藥市場分析·預測
  • 波特的五力分析

第5章 主要洞察

  • 開發平台分析
  • 主要的M&A
  • COVID-19影響分析

第6章 全球疼痛管理藥市場分析·預測:各治療藥物

  • 簡介·定義
  • 主要調查結果/展開
  • 市場規模·預測
    • 抗痙攣藥
    • 抗憂鬱症藥
    • 麻醉劑
    • 非類固醇系抗發炎藥 (NSAIDS)
    • 類鴉片物質
    • 其他的非麻醉劑止痛藥
    • 偏頭痛藥
  • 市場魅力

第7章 全球疼痛管理藥市場分析·預測:各適應症

  • 簡介·定義
  • 主要調查結果/展開
  • 市場規模·預測
    • 神經性疼痛
    • 纖維肌痛症
    • 關節痛
    • 慢性腰痛
    • 偏頭痛
    • 手術後疼痛
    • 癌症性疼痛
  • 市場魅力

第8章 全球疼痛管理藥市場分析·預測:各管理途徑

  • 簡介·定義
  • 主要調查結果/展開
  • 市場規模·預測
    • 口服
    • 非口服
    • 其他
  • 市場魅力

第9章 全球疼痛管理藥市場分析·預測:各流通管道

  • 簡介·定義
  • 主要調查結果/展開
  • 市場規模·預測
    • 零售藥局
    • 線上藥局
    • 其他
  • 市場魅力

第10章 全球疼痛管理藥市場分析·預測:各地區

  • 主要調查結果
  • 市場規模·預測
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東·非洲
  • 市場魅力

第11章 北美的疼痛管理藥市場分析·預測

第12章 歐洲的疼痛管理藥市場分析·預測

第13章 亞太地區的疼痛管理藥市場分析·預測

第14章 南美的疼痛管理藥市場分析·預測

第15章 中東·非洲的疼痛管理藥市場分析·預測

第16章 競爭情形

  • 參與企業·競爭矩陣
  • 市場佔有率分析:各企業
  • 企業簡介
    • Abbott Laboratories
    • AstraZeneca plc
    • Pfizer, Inc.
    • Depomed, Inc.
    • Endo International plc
    • GlaxoSmithKline plc
Product Code: TMRGL1059

TMR's report on the global pain management therapeutics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global pain management therapeutics market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global pain management therapeutics market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the pain management therapeutics market.

The report delves into the competitive landscape of the global pain management therapeutics market. Key players operating in the global pain management therapeutics market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global pain management therapeutics market profiled in this report.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Pain Management Therapeutics Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Therapeutics Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Pain Management Therapeutics Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Mn)
  • 4.5. Porter's Five Force Analysis

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Mergers & Acquisitions
  • 5.3. Covid 19 Impact Analysis

6. Global Pain Management Therapeutics Market Analysis and Forecast, by Therapeutic

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Therapeutic, 2017-2031
    • 6.3.1. Anticonvulsants
    • 6.3.2. Antidepressants
    • 6.3.3. Anesthetics
    • 6.3.4. Non-steroidal Anti-inflammatory Drugs (NSAIDS)
    • 6.3.5. Opioids
    • 6.3.6. Other Non-narcotic Analgesic
    • 6.3.7. Antimigraine Agents
  • 6.4. Market Attractiveness Analysis, by Therapeutic

7. Global Pain Management Therapeutics Market Analysis and Forecast, by Indication

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Indication, 2017-2031
    • 7.3.1. Neuropathic Pain
    • 7.3.2. Fibromyalgia
    • 7.3.3. Arthritic Pain
    • 7.3.4. Chronic Back Pain
    • 7.3.5. Migraine
    • 7.3.6. Post-operative Pain
    • 7.3.7. Cancer Pain
  • 7.4. Market Attractiveness Analysis, by Indication

8. Global Pain Management Therapeutics Market Analysis and Forecast, by Route of Administration

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast, by Route of Administration, 2017-2031
    • 8.3.1. Oral
    • 8.3.2. Parenteral
    • 8.3.3. Others
  • 8.4. Market Attractiveness Analysis, by Route of Administration

9. Global Pain Management Therapeutics Market Analysis and Forecast, by Distribution Channel

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 9.3.1. Retail Pharmacies
    • 9.3.2. Online Pharmacies
    • 9.3.3. Others
  • 9.4. Market Attractiveness Analysis, by Distribution Channel

10. Global Pain Management Therapeutics Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness Analysis, by Region

11. North America Pain Management Therapeutics Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Therapeutic, 2017-2031
    • 11.2.1. Anticonvulsants
    • 11.2.2. Antidepressants
    • 11.2.3. Anesthetics
    • 11.2.4. Non-steroidal Anti-inflammatory Drugs (NSAIDS)
    • 11.2.5. Opioids
    • 11.2.6. Other Non-narcotic Analgesic
    • 11.2.7. Antimigraine Agents
  • 11.3. Market Value Forecast, by Indication, 2017-2031
    • 11.3.1. Neuropathic Pain
    • 11.3.2. Fibromyalgia
    • 11.3.3. Arthritic Pain
    • 11.3.4. Chronic Back Pain
    • 11.3.5. Migraine
    • 11.3.6. Post-operative Pain
    • 11.3.7. Cancer Pain
  • 11.4. Market Value Forecast, by Route of Administration, 2017-2031
    • 11.4.1. Oral
    • 11.4.2. Parenteral
    • 11.4.3. Others
  • 11.5. Market Value Forecast, by Distribution Channel, 2017-2031
    • 11.5.1. Retail Pharmacies
    • 11.5.2. Online Pharmacies
    • 11.5.3. Others
  • 11.6. Market Value Forecast, by Country, 2017-2031
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Therapeutic
    • 11.7.2. By Indication
    • 11.7.3. By Route of Administration
    • 11.7.4. By Distribution Channel
    • 11.7.5. By Country

12. Europe Pain Management Therapeutics Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Therapeutic, 2017-2031
    • 12.2.1. Anticonvulsants
    • 12.2.2. Antidepressants
    • 12.2.3. Anesthetics
    • 12.2.4. Non-steroidal Anti-inflammatory Drugs (NSAIDS)
    • 12.2.5. Opioids
    • 12.2.6. Other Non-narcotic Analgesic
    • 12.2.7. Antimigraine Agents
  • 12.3. Market Value Forecast, by Indication, 2017-2031
    • 12.3.1. Neuropathic Pain
    • 12.3.2. Fibromyalgia
    • 12.3.3. Arthritic Pain
    • 12.3.4. Chronic Back Pain
    • 12.3.5. Migraine
    • 12.3.6. Post-operative Pain
    • 12.3.7. Cancer Pain
  • 12.4. Market Value Forecast, by Route of Administration, 2017-2031
    • 12.4.1. Oral
    • 12.4.2. Parenteral
    • 12.4.3. Others
  • 12.5. Market Value Forecast, by Distribution Channel, 2017-2031
    • 12.5.1. Retail Pharmacies
    • 12.5.2. Online Pharmacies
    • 12.5.3. Others
  • 12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.6.1. Germany
    • 12.6.2. U.K.
    • 12.6.3. France
    • 12.6.4. Spain
    • 12.6.5. Italy
    • 12.6.6. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Therapeutic
    • 12.7.2. By Indication
    • 12.7.3. By Route of Administration
    • 12.7.4. By Distribution Channel
    • 12.7.5. By Country/Sub-region

13. Asia Pacific Pain Management Therapeutics Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Therapeutic, 2017-2031
    • 13.2.1. Anticonvulsants
    • 13.2.2. Antidepressants
    • 13.2.3. Anesthetics
    • 13.2.4. Non-steroidal Anti-inflammatory Drugs (NSAIDS)
    • 13.2.5. Opioids
    • 13.2.6. Other Non-narcotic Analgesic
    • 13.2.7. Antimigraine Agents
  • 13.3. Market Value Forecast, by Indication, 2017-2031
    • 13.3.1. Neuropathic Pain
    • 13.3.2. Fibromyalgia
    • 13.3.3. Arthritic Pain
    • 13.3.4. Chronic Back Pain
    • 13.3.5. Migraine
    • 13.3.6. Post-operative Pain
    • 13.3.7. Cancer Pain
  • 13.4. Market Value Forecast, by Route of Administration, 2017-2031
    • 13.4.1. Oral
    • 13.4.2. Parenteral
    • 13.4.3. Others
  • 13.5. Market Value Forecast, by Distribution Channel, 2017-2031
    • 13.5.1. Retail Pharmacies
    • 13.5.2. Online Pharmacies
    • 13.5.3. Others
  • 13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.6.1. China
    • 13.6.2. Japan
    • 13.6.3. India
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Therapeutic
    • 13.7.2. By Indication
    • 13.7.3. By Route of Administration
    • 13.7.4. By Distribution Channel
    • 13.7.5. By Country/Sub-region

14. Latin America Pain Management Therapeutics Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Therapeutic, 2017-2031
    • 14.2.1. Anticonvulsants
    • 14.2.2. Antidepressants
    • 14.2.3. Anesthetics
    • 14.2.4. Non-steroidal Anti-inflammatory Drugs (NSAIDS)
    • 14.2.5. Opioids
    • 14.2.6. Other Non-narcotic Analgesic
    • 14.2.7. Antimigraine Agents
  • 14.3. Market Value Forecast, by Indication, 2017-2031
    • 14.3.1. Neuropathic Pain
    • 14.3.2. Fibromyalgia
    • 14.3.3. Arthritic Pain
    • 14.3.4. Chronic Back Pain
    • 14.3.5. Migraine
    • 14.3.6. Post-operative Pain
    • 14.3.7. Cancer Pain
  • 14.4. Market Value Forecast, by Route of Administration, 2017-2031
    • 14.4.1. Oral
    • 14.4.2. Parenteral
    • 14.4.3. Others
  • 14.5. Market Value Forecast, by Distribution Channel, 2017-2031
    • 14.5.1. Retail Pharmacies
    • 14.5.2. Online Pharmacies
    • 14.5.3. Others
  • 14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Therapeutic
    • 14.7.2. By Indication
    • 14.7.3. By Route of Administration
    • 14.7.4. By Distribution Channel
    • 14.7.5. By Country/Sub-region

15. Middle East & Africa Pain Management Therapeutics Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Therapeutic, 2017-2031
    • 15.2.1. Anticonvulsants
    • 15.2.2. Antidepressants
    • 15.2.3. Anesthetics
    • 15.2.4. Non-steroidal Anti-inflammatory Drugs (NSAIDS)
    • 15.2.5. Opioids
    • 15.2.6. Other Non-narcotic Analgesic
    • 15.2.7. Antimigraine Agents
  • 15.3. Market Value Forecast, by Indication, 2017-2031
    • 15.3.1. Neuropathic Pain
    • 15.3.2. Fibromyalgia
    • 15.3.3. Arthritic Pain
    • 15.3.4. Chronic Back Pain
    • 15.3.5. Migraine
    • 15.3.6. Post-operative Pain
    • 15.3.7. Cancer Pain
  • 15.4. Market Value Forecast, by Route of Administration, 2017-2031
    • 15.4.1. Oral
    • 15.4.2. Parenteral
    • 15.4.3. Others
  • 15.5. Market Value Forecast, by Distribution Channel, 2017-2031
    • 15.5.1. Retail Pharmacies
    • 15.5.2. Online Pharmacies
    • 15.5.3. Others
  • 15.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Therapeutic
    • 15.7.2. By Indication
    • 15.7.3. By Route of Administration
    • 15.7.4. By Distribution Channel
    • 15.7.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (by tier and size of companies)
  • 16.2. Market Share Analysis, by Company, 2021
  • 16.3. Company Profiles
    • 16.3.1. Abbott Laboratories
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Financial Analysis
      • 16.3.1.3. Growth Strategies
      • 16.3.1.4. SWOT Analysis
    • 16.3.2. AstraZeneca plc
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Financial Analysis
      • 16.3.2.3. Growth Strategies
      • 16.3.2.4. SWOT Analysis
    • 16.3.3. Pfizer, Inc.
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Financial Analysis
      • 16.3.3.3. Growth Strategies
      • 16.3.3.4. SWOT Analysis
    • 16.3.4. Depomed, Inc.
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Financial Analysis
      • 16.3.4.3. Growth Strategies
      • 16.3.4.4. SWOT Analysis
    • 16.3.5. Endo International plc
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Financial Analysis
      • 16.3.5.3. Growth Strategies
      • 16.3.5.4. SWOT Analysis
    • 16.3.6. GlaxoSmithKline plc
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Financial Analysis

List of Tables

  • Table 01: Global Pain Management Therapeutics Market Value Share, by Therapeutic, 2021
  • Table 02: Global Pain Management Therapeutics Market Value Share, by Indication, 2021
  • Table 03: Global Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Therapeutic, 2017-2031
  • Table 04: Global Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Indication, 2017-2031
  • Table 05: Global Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2031
  • Table 06: Global Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 07: Global Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 08: North America Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Therapeutic, 2017-2031
  • Table 09: North America Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Indication, 2017-2031
  • Table 10: North America Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2031
  • Table 11: North America Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 12: North America Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 13: Europe Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Therapeutic, 2017-2031
  • Table 14: Europe Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Indication, 2017-2031
  • Table 15: Europe Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2031
  • Table 16: Europe Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 17: Europe Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 18: Asia Pacific Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Therapeutic, 2017-2031
  • Table 19: Asia Pacific Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Indication, 2017-2031
  • Table 20: Asia Pacific Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2031
  • Table 21: Asia Pacific Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 22: Asia Pacific Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 23: Latin America Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Therapeutic, 2017-2031
  • Table 24: Latin America Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Indication, 2017-2031
  • Table 25: Latin America Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2031
  • Table 26: Latin America Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 27: Latin America Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 28: Middle East & Africa Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Therapeutic, 2017-2031
  • Table 29: Middle East & Africa Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Indication, 2017-2031
  • Table 30: Middle East & Africa Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2031
  • Table 31: Middle East & Africa Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 32: Middle East & Africa Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

List of Figures

  • Figure 01: Global Pain Management Therapeutics Market Snapshot
  • Figure 02: Global Pain Management Therapeutics Market Segments With Leading Market Share (%), 2021
  • Figure 03: Key Industry Developments (Pain Management Therapeutics Market)
  • Figure 04: Global Pain Management Therapeutics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 05: Global Pain Management Therapeutics Market Value Share (%), by Therapeutic (2021)
  • Figure 06: Global Pain Management Therapeutics Market Value Share (%), by Indication (2021)
  • Figure 07: Global Pain Management Therapeutics Market Value Share (%), by Route of Administration (2021)
  • Figure 08: Global Pain Management Therapeutics Market Value Share(%), by Distribution Channel (2021)
  • Figure 09: Global Pain Management Therapeutics Market Value Share (%), by Region (2021)
  • Figure 10: Global Pain Management Therapeutics Market Value Share Analysis, by Therapeutic, 2021 and 2031
  • Figure 11: Global Pain Management Therapeutics Market Attractiveness Analysis, by Therapeutic, 2022-2031
  • Figure 12: Global Pain Management Therapeutics Market Value Share Analysis, by Indication, 2021 and 2031
  • Figure 13: Global Pain Management Therapeutics Market Attractiveness Analysis, by Indication, 2022-2031
  • Figure 14: Global Pain Management Therapeutics Market Value Share Analysis, by Route of Administration, 2021 and 2031
  • Figure 15: Global Pain Management Therapeutics Market Attractiveness Analysis, by Route of Administration, 2022-2031
  • Figure 16: Global Pain Management Therapeutics Market Value Share(%), by Distribution Channel, 2021 and 2031
  • Figure 17: Global Pain Management Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 18: Global Pain Management Therapeutics Market Value Share Analysis, by Region 2021 and 2031
  • Figure 19: Global Pain Management Therapeutics Market Attractiveness Analysis, by Region, 2022-2031
  • Figure 20: North America Pain Management Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2031
  • Figure 21: North America Pain Management Therapeutics Market Value Share (%), by Therapeutic, 2021 and 2031
  • Figure 22: North America Pain Management Therapeutics Market Attractiveness Analysis, by Therapeutic, 2022-2031
  • Figure 23: North America Pain Management Therapeutics Market Value Share (%), by Indication, 2021 and 2031
  • Figure 24: North America Pain Management Therapeutics Market Attractiveness Analysis, by Indication, 2022-2031
  • Figure 25: North America Pain Management Therapeutics Market Value Share (%), by Route of Administration, 2021 and 2031
  • Figure 26: North America Pain Management Therapeutics Market Attractiveness Analysis, by Route of Administration, 2022-2031
  • Figure 27: North America Pain Management Therapeutics Market Share (%), by Distribution Channel, 2021 and 2031
  • Figure 28: North America Pain Management Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 29: North America Pain Management Therapeutics Market Value Share (%), by Country, 2021 and 2031
  • Figure 30: North America Pain Management Therapeutics Market Attractiveness Analysis, by Country, 2022-2031
  • Figure 31: Europe Pain Management Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2031
  • Figure 32: Europe Pain Management Therapeutics Market Value Share (%), by Therapeutic, 2021 and 2031
  • Figure 33: Europe Pain Management Therapeutics Market Attractiveness Analysis, by Therapeutic, 2022-2031
  • Figure 34: Europe Pain Management Therapeutics Market Value Share (%), by Indication, 2021 and 2031
  • Figure 35: Europe Pain Management Therapeutics Market Attractiveness Analysis, by Indication, 2022-2031
  • Figure 36: Europe Pain Management Therapeutics Market Value Share (%), by Route of Administration, 2021 and 2031
  • Figure 37: Europe Pain Management Therapeutics Market Attractiveness Analysis, by Route of Administration, 2022-2031
  • Figure 38: Europe Pain Management Therapeutics Market Share (%), by Distribution Channel, 2021 and 2031
  • Figure 39: Europe Pain Management Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 40: Europe Pain Management Therapeutics Market Value Share (%), by Country/Sub-region, 2021 and 2031
  • Figure 41: Europe Pain Management Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 42: Asia Pacific Pain Management Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2031
  • Figure 43: Asia Pacific Pain Management Therapeutics Market Value Share (%), by Therapeutic, 2021 and 2031
  • Figure 44: Asia Pacific Pain Management Therapeutics Market Attractiveness Analysis, by Therapeutic, 2022-2031
  • Figure 45: Asia Pacific Pain Management Therapeutics Market Value Share (%), by Indication, 2021 and 2031
  • Figure 46: Asia Pacific Pain Management Therapeutics Market Attractiveness Analysis, by Indication, 2022-2031
  • Figure 47: Asia Pacific Pain Management Therapeutics Market Value Share (%), by Route of Administration, 2021 and 2031
  • Figure 48: Asia Pacific Pain Management Therapeutics Market Attractiveness Analysis, by Route of Administration, 2022-2031
  • Figure 49: Asia Pacific Pain Management Therapeutics Market Share (%), by Distribution Channel, 2021 and 2031
  • Figure 50: Asia Pacific Pain Management Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 51: Asia Pacific Pain Management Therapeutics Market Value Share (%), by Country/Sub-region, 2021 and 2031
  • Figure 52: Asia Pacific Pain Management Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 53: Latin America Pain Management Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2031
  • Figure 54: Latin America Pain Management Therapeutics Market Value Share (%), by Therapeutic, 2021 and 2031
  • Figure 55: Latin America Pain Management Therapeutics Market Attractiveness Analysis, by Therapeutic, 2022-2031
  • Figure 56: Latin America Pain Management Therapeutics Market Value Share (%), by Indication, 2021 and 2031
  • Figure 57: Latin America Pain Management Therapeutics Market Attractiveness Analysis, by Indication, 2022-2031
  • Figure 58: Latin America Pain Management Therapeutics Market Value Share (%), by Route of Administration, 2021 and 2031
  • Figure 59: Latin America Pain Management Therapeutics Market Attractiveness Analysis, by Route of Administration, 2022-2031
  • Figure 60: Latin America Pain Management Therapeutics Market Share (%), by Distribution Channel, 2021 and 2031
  • Figure 61: Latin America Pain Management Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 62: Latin America Pain Management Therapeutics Market Value Share (%), by Country/Sub-region, 2021 and 2031
  • Figure 63: Latin America Pain Management Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 64: Middle East & Africa Pain Management Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2031
  • Figure 65: Middle East & Africa Pain Management Therapeutics Market Value Share (%), by Therapeutic, 2021 and 2031
  • Figure 66: Middle East & Africa Pain Management Therapeutics Market Attractiveness Analysis, by Therapeutic, 2022-2031
  • Figure 67: Middle East & Africa Pain Management Therapeutics Market Value Share (%), by Indication, 2021 and 2031
  • Figure 68: Middle East & Africa Pain Management Therapeutics Market Attractiveness Analysis, by Indication, 2022-2031
  • Figure 69: Middle East & Africa Pain Management Therapeutics Market Value Share (%), by Route of Administration, 2021 and 2031
  • Figure 70: Middle East & Africa Pain Management Therapeutics Market Attractiveness Analysis, by Route of Administration, 2022-2031
  • Figure 71: Middle East & Africa Pain Management Therapeutics Market Share (%), by Distribution Channel, 2021 and 2031
  • Figure 72: Middle East & Africa Pain Management Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 73: Middle East & Africa Pain Management Therapeutics Market Value Share (%), by Country/Sub-region, 2021 and 2031
  • Figure 74: Middle East & Africa Pain Management Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2022-2031